Singapore: Esco Lifesciences Group attracts US$200m in Series A financing

Esco Lifesciences

Novo Holdings and Vivo Capital have co-led an oversubscribed US$200m Series A financing for Singapore-based life sciences tools company, Esco Lifesciences Group. It is the largest private financing round by an Asia-based life sciences tools company. The financing will enable Esco, a manufacturer of laboratory and biopharma equipment and IVF medical devices, to strengthen its…

You must be a HMI Subscriber to view this content.

Subscribe Now »